Search Results - garth+ehrlich

1 Results Sort By:
RelA Inhibitor as a Anti-microbial Therapy
Value Proposition:·        Unique mechanism of action that targets antibiotic-resistant infections·        Ability to target multiple stress resistance mechanisms in bacteria·        Broad range of application  Technology Description·        Researchers at Johns Hopkins have developed an antibacterial small molecule inhibitor that can be used to treat...
Published: 3/13/2026   |   Inventor(s): Nathan Archer, Garth Ehrlich, Donald Hall
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Infectious Diseases
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum